Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:508146rdf:typepubmed:Citationlld:pubmed
pubmed-article:508146lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:508146lifeskim:mentionsumls-concept:C0008925lld:lifeskim
pubmed-article:508146lifeskim:mentionsumls-concept:C0232910lld:lifeskim
pubmed-article:508146lifeskim:mentionsumls-concept:C0006949lld:lifeskim
pubmed-article:508146lifeskim:mentionsumls-concept:C0031507lld:lifeskim
pubmed-article:508146lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:508146lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:508146pubmed:issue13lld:pubmed
pubmed-article:508146pubmed:dateCreated1980-1-24lld:pubmed
pubmed-article:508146pubmed:abstractTextThe teratogenic activity of two anticonvulsant drugs, phenytoin sodium and carbamazepine, was studied in pregnant mice fed phenytoin and carbamazepine during days 8 to 13. Incidence of palatal defects and other abnormalities correlated with increasing dosages and blood levels of the drugs. Phenytoin produced a much higher incidence of teratogenic effects than carbamazepine.lld:pubmed
pubmed-article:508146pubmed:languageenglld:pubmed
pubmed-article:508146pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:508146pubmed:citationSubsetAIMlld:pubmed
pubmed-article:508146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:508146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:508146pubmed:statusMEDLINElld:pubmed
pubmed-article:508146pubmed:monthDeclld:pubmed
pubmed-article:508146pubmed:issn0003-9942lld:pubmed
pubmed-article:508146pubmed:authorpubmed-author:PaulsonG WGWlld:pubmed
pubmed-article:508146pubmed:authorpubmed-author:PaulsonR BRBlld:pubmed
pubmed-article:508146pubmed:authorpubmed-author:JreissatySSlld:pubmed
pubmed-article:508146pubmed:issnTypePrintlld:pubmed
pubmed-article:508146pubmed:volume36lld:pubmed
pubmed-article:508146pubmed:ownerNLMlld:pubmed
pubmed-article:508146pubmed:authorsCompleteYlld:pubmed
pubmed-article:508146pubmed:pagination832-6lld:pubmed
pubmed-article:508146pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-A...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-M...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-P...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-C...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-P...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-F...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-D...lld:pubmed
pubmed-article:508146pubmed:meshHeadingpubmed-meshheading:508146-C...lld:pubmed
pubmed-article:508146pubmed:year1979lld:pubmed
pubmed-article:508146pubmed:articleTitlePhenytoin and carbamazepine in production of cleft palates in mice. Comparison of teratogenic effects.lld:pubmed
pubmed-article:508146pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:508146lld:pubmed